Cardiology Review - Issue 2/2012
72
Current guidelines for antiplatelet therapy in neurology
R. Herzig, M. Král
79
Anticoagulant therapy and atrial fibrillation
R. Lábrová, J. Špinar
88
New peroral antithrombotics in the prevention and treatment of tromboembolism
D. Karetová, J. Bultas
97
Current possibilities of monitoring of antithrombotic therapy – new antithrombotic drugs
A. Buliková, J. Zavřelová, M. Matýšková
Reports from Foreign countries
109
Vorapaxar in clinical studies
J. Špinar, J. Vítovec, L. Špinarová
115
What is vernakalant and what is its place in clinical practice?
J. Murín, J. Vítovec
121
Eprosartan – dual blocker of AT1 receptors
J. Špinar, J. Vítovec, L. Špinarová
Case Report
126
Case report - competitive
130
Heart Transplant Patient with Invasive Pulmonary Aspergillosis
P. Šajgalík, L. Špinarová, P. Hude, J. Krejčí, J. Godava, M. Tošková, Z. Ráčil, J. Vítovec, P. Němec
Cardiology Review
2012 Číslo 2
Najčítanejšie v tomto čísle
- Antiaggregating and anticoagulant therapy – basic principles
- Anticoagulant therapy and atrial fibrillation
- Where is a step in the current development of drugs that affect blood clotting?
- Current guidelines for antiplatelet therapy in neurology